Literature DB >> 17129771

Re-evaluating cell-cycle regulation by E2Fs.

Benjamin D Rowland1, René Bernards.   

Abstract

Activation of E2F transcription factors is thought to drive the expression of genes essential for the transition of cells from G1 to S phase and for the initiation of DNA replication. However, this textbook view of E2Fs is increasingly under challenge. Here we discuss an alternative model for how E2Fs may work.

Mesh：

Substances：

Year:  2006        PMID： 17129771     DOI： 10.1016/j.cell.2006.11.019

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  42 in total

1.  Dual functions of DP1 promote biphasic Wnt-on and Wnt-off states during anteroposterior neural patterning.

Authors:  Wan-Tae Kim; Hyunjoon Kim; Vladimir L Katanaev; Seung Joon Lee; Tohru Ishitani; Boksik Cha; Jin-Kwan Han; Eek-Hoon Jho
Journal:  EMBO J       Date:  2012-07-06       Impact factor: 11.598

2.  The zinc finger transcription factor ZFHX1A is linked to cell proliferation by Rb-E2F1.

Authors:  Yongqing Liu; Mary E Costantino; Diego Montoya-Durango; Yujiro Higashi; Douglas S Darling; Douglas C Dean
Journal:  Biochem J       Date:  2007-11-15       Impact factor: 3.857

3.  Targeting Rb inactivation in cancers by synthetic lethality.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Am J Cancer Res       Date:  2011-06-30       Impact factor: 6.166

4.  Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.

Authors:  Marianna Penzo; Paul E Massa; Eleonora Olivotto; Francesca Bianchi; Rosa Maria Borzi; Adedayo Hanidu; Xiang Li; Jun Li; Kenneth B Marcu
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

5.  Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis.

Authors:  Jan-Henning Klusmann; Frank J Godinho; Kirsten Heitmann; Aliaksandra Maroz; Mia Lee Koch; Dirk Reinhardt; Stuart H Orkin; Zhe Li
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

6.  E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer.

Authors:  Chao Cheng; Frederick S Varn; Carmen J Marsit
Journal:  Mol Cancer Res       Date:  2015-06-01       Impact factor: 5.852

7.  Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.

Authors:  Eriko Suzuki; Yue Zhao; Saya Ito; Shun Sawatsubashi; Takuya Murata; Takashi Furutani; Yuko Shirode; Kaoru Yamagata; Masahiko Tanabe; Shuhei Kimura; Takashi Ueda; Sally Fujiyama; Jinseon Lim; Hiroyuki Matsukawa; Alexander P Kouzmenko; Toshiro Aigaki; Tetsuya Tabata; Ken-ichi Takeyama; Shigeaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  Division and apoptosis of E2f-deficient retinal progenitors.

Authors:  Danian Chen; Marek Pacal; Pamela Wenzel; Paul S Knoepfler; Gustavo Leone; Rod Bremner
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

9.  E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.

Authors:  Jean-Leon Chong; Pamela L Wenzel; M Teresa Sáenz-Robles; Vivek Nair; Antoney Ferrey; John P Hagan; Yorman M Gomez; Nidhi Sharma; Hui-Zi Chen; Madhu Ouseph; Shu-Huei Wang; Prashant Trikha; Brian Culp; Louise Mezache; Douglas J Winton; Owen J Sansom; Danian Chen; Rod Bremner; Paul G Cantalupo; Michael L Robinson; James M Pipas; Gustavo Leone
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

10.  Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

Authors:  M Chehani Alles; Margaret Gardiner-Garden; David J Nott; Yixin Wang; John A Foekens; Robert L Sutherland; Elizabeth A Musgrove; Christopher J Ormandy
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.